טוען...

A Receptor Tyrosine Kinase Network Composed of Fibroblast Growth Factor Receptors, Epidermal Growth Factor Receptor, v-erb-b2 Erythroblastic Leukemia Viral Oncogene Homolog 2, and Hepatocyte Growth Factor Receptor Drives Growth and Survival of Head and Neck Squamous Carcinoma Cell Lines

Our laboratory has previously shown that some gefitinib-insensitive head and neck squamous cell carcinoma (HNSCC) cell lines exhibit dominant autocrine fibroblast growth factor receptor (FGFR) signaling. Herein, we deployed a whole-genome loss-of-function screen to identify genes whose knockdown pot...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Singleton, Katherine R., Kim, Jihye, Hinz, Trista K., Marek, Lindsay A., Casás-Selves, Matias, Hatheway, Clark, Tan, Aik Choon, DeGregori, James, Heasley, Lynn E.
פורמט: Artigo
שפה:Inglês
יצא לאור: The American Society for Pharmacology and Experimental Therapeutics 2013
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3608435/
https://ncbi.nlm.nih.gov/pubmed/23371912
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/mol.112.084111
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!